Tibor Szük

Hungary

MD, PhD

Senior lecturer at University of Debrecen, Hungary.

CLINICAL EXPERIENCES: 1994- : cardiac catheterization;1999- : coronary intervention; 2002- : coronary intervention is acute coronary syndrome; 2012- : renal denervation, rotablation; 2015-: anterograde and later retrograde CTO interventions; 2017-: BPA (balloon pulmonary angioplasty); 2022-: TAVI and orbital atherectomy procedures

PROFESSIONAL SOCIETY MEMBERSHIP: Hungarian Society of Cardiology, European Society of Cardiology (ESC), European Association of Percutaneous Cardiovascular Intervention, ESC Working Group on Thrombosis, 2020-2022 Member of the EAPCI Training and Certification Comittee, 2020-2022 Vice president of the Hungarian Society of Cardiology – Working Group on Interventional Cardiology

RESEARCH EXPERIENCE: 2008. PhD degree at University of Debrecen: Analysing of different schemes of clopidogrel therapy after intracoronary stent implantation (summa cum laude), supervisor at Laki Kalman Doctoral School, University of Debrecen: 1 PhD student graduated in 2024, 1 PhD student is before graduation

PROCTORSHIPS: 2014. Vessix V2 Launch proctoring (Kazakhstan), 2020- : rotablation proctoring in Hungary

REVIEWER: Frontiers in Cardiovascular Medicine, Journal of Clinical Medicine

INVESTIGATOR OR CO-INVESTIGATOR IN STUDIES:  OASIS II, EXCITE, VALIANT, VIAGRA, SYMPHONY, PARAGON-B, DUAAL, ONTARGET/TRANSCEND¬, EMPHASIS-HF, REDEEM, AQUARIUS, ATLANTIC, GLAGOV, MODIFY, CARAT, COOL-AMI, MORPHEUS, CLEAR SYNERGY (OASIS-9)